Income statement
USD
Annual
| Metric | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|
| Revenue | 876K | 208K | 247K | 0 |
| Gross Profit | 484K | 113K | 45K | -958 |
| Operating Income | -512K | -43K | -41K | -126K |
| EBITDA | -512K | -43K | -41K | -125K |
| Net Income | -512K | -42K | -41K | -126K |
| EPS (Diluted) | — | — | — | — |
Healthcare
Live Price
Offline$0.00005
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Profile Solutions, Inc. (PSIQ) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +320.9%, EPS growth of -600.0%, a dividend yield of 0.0%. What stands out right now is revenue +320.9%, EPS -600.0%, free cash flow -537.2% with operating margin -58.4% and ROIC -104.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PSIQ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PSIQ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PSIQ Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PSIQ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$126.2K
-206.4% YoY
Free Cash Flow
-$64.5K
-60.1% YoY
Revenue Growth
+320.9%
EPS Growth
-600.0%
Gross Margin
55.3%
Net Margin
-58.4%
Income statement
USD
| Metric | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|
| Revenue | 876K | 208K | 247K | 0 |
| Gross Profit | 484K | 113K | 45K | -958 |
| Operating Income | -512K | -43K | -41K | -126K |
| EBITDA | -512K | -43K | -41K | -125K |
| Net Income | -512K | -42K | -41K | -126K |
| EPS (Diluted) | — | — | — | — |
Balance sheet
USD
| Metric | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|
| Cash & Equivalents | 108K | 48K | 70 | 710 |
| Total Assets | 570K | 138K | 6K | 54K |
| Total Liabilities | 85K | 33K | 47K | 32K |
| Shareholder Equity | 485K | 106K | -41K | 22K |
| Total Debt | 6K | 0 | 0 | 0 |
| Net Debt | -101K | -48K | -70 | -710 |
Cash flow positioning
Latest Full Year
Operating Cash Flow
65K
-60.1% YoY
Capital Expenditures
0
Free Cash Flow
65K
-60.1% YoY
Key ratios
Gross Margin
55.3%
Operating Margin
-58.4%
Net Margin
-58.4%
ROE
-173.4%
Debt / Equity
0.01x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.